InvestorsHub Logo
Followers 38
Posts 2285
Boards Moderated 0
Alias Born 12/23/2011

Re: cvinvestor post# 14583

Friday, 06/12/2015 7:05:33 PM

Friday, June 12, 2015 7:05:33 PM

Post# of 118384
Thank you for a great post!

I see this as potential revenue stream for licensing to companies whose research is not directly in competition to RGBP.


Your reference to the patent covering screening for small molecules that can turn on the nuclear receptor leading to the ability to expand cord blood cells for bone marrow transplantation is very relevant.

Looking to a great future for this company, future patients, and the stockholders.